Cumberland Pharmaceuticals (CPIX) Gross Profit Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.46 Mn | 110.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.04% |
| Dec 31, 2025 | 35.21% |
| Sep 30, 2025 | -5.92% |
| Jun 30, 2025 | 8.46% |
| Mar 31, 2025 | 48.61% |
| Dec 31, 2024 | 8.13% |
| Sep 30, 2024 | -6.70% |
| Jun 30, 2024 | -13.13% |
| Mar 31, 2024 | -13.19% |
| Dec 31, 2023 | 20.85% |
| Sep 30, 2023 | -9.45% |
| Jun 30, 2023 | 13.32% |
| Mar 31, 2023 | -11.03% |
| Dec 31, 2022 | 29.61% |
| Sep 30, 2022 | 36.24% |
| Jun 30, 2022 | 13.02% |
| Mar 31, 2022 | 10.39% |
| Dec 31, 2021 | -37.53% |
| Sep 30, 2021 | -5.11% |
| Jun 30, 2021 | 4.67% |